When a physician assistant prescribes a C2-C3 substance, what documentation must an MD have?

The requirement for a physician assistant (PA) to prescribe a Schedule II or Schedule III controlled substance hinges on the delegation agreement established with the supervising physician. In Connecticut, this agreement must outline the protocols and procedures by which a PA can prescribe medications, including controlled substances.

When a PA does prescribe these substances, the supervising physician must ensure that there is proper documentation in the medical record reflecting this approval. This documentation serves several purposes: it assures compliance with state regulations, provides a clear record for future healthcare providers involved in the patient’s care, and helps to safeguard against potential legal ramifications related to the prescribing of controlled substances.

The requirement for documentation aligns with the overall regulatory framework governing PAs and the supervisory responsibilities of physicians. It reinforces accountability and ensures that patient care is coordinated and well-informed, reflecting the collaborative nature of healthcare delivery.

In context, other options fall short; simply having approval noted in the patient's chart or relying on verbal approval lacks the necessary formalization and could lead to ambiguities about the prescribing authority. Stating that no documentation is necessary contradicts the regulations governing the practice and might compromise patient safety and legal compliance. Hence, thorough documentation in accordance with the delegation agreement is essential to uphold the integrity of the prescribing process.